Lipe & Dalton Johnson & Johnson Transaction History

Lipe & Dalton

$186 Million
Q2 2024

A detailed history of Lipe & Dalton transactions in Johnson & Johnson stock. As of the latest transaction made, Lipe & Dalton holds 8,143 shares of JNJ stock, worth $1.34 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

8,143

Previous 7,842 3.84%

Holding current value

$1.34 Million

Previous $1.24 Million 4.11%

% of portfolio

0.64%

Previous 0.64%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$144.38 - $157.78 $43,458 - $47,491	301 Added 3.84%	8,143 $1.19 Million
Q4 2023 Jan 30, 2024	SELL	$145.6 - $158.88 $28,974 - $31,617	-199 Reduced 2.47%	7,842 $1.23 Million
Q3 2023 Nov 03, 2023	BUY	$155.75 - $174.48 $93,450 - $104,688	600 Added 8.06%	8,041 $1.25 Million
Q2 2023 Jul 26, 2023	BUY	$154.35 - $166.11 $44,915 - $48,338	291 Added 4.07%	7,441 $1.23 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $151 - $180	1 Added 0.01%	7,150 $1.11 Million
Q4 2022 Feb 03, 2023	BUY	$160.2 - $179.79 $160 - $179	1 Added 0.01%	7,149 $1.26 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $54,829 - $60,639	326 Added 4.78%	7,148 $1.27 Million
Q1 2022 Apr 26, 2022	SELL	$158.14 - $179.59 $43,962 - $49,926	-278 Reduced 3.92%	6,822 $1.21 Million
Q4 2021 Feb 01, 2022	SELL	$155.93 - $173.01 $20,738 - $23,010	-133 Reduced 1.84%	7,100 $1.22 Million
Q3 2021 Nov 01, 2021	SELL	$161.5 - $179.47 $3,876 - $4,307	-24 Reduced 0.33%	7,233 $1.17 Million
Q2 2021 Aug 02, 2021	BUY	$159.48 - $171.07 $159 - $171	1 Added 0.01%	7,257 $1.2 Million
Q1 2021 Apr 30, 2021	BUY	$153.07 - $170.48 $14,694 - $16,366	96 Added 1.34%	7,256 $1.19 Million
Q4 2020 Jan 29, 2021	BUY	$137.11 - $157.38 $65,127 - $74,755	475 Added 7.11%	7,160 $1.13 Million
Q3 2020 Oct 30, 2020	SELL	$140.38 - $153.83 $17,407 - $19,074	-124 Reduced 1.82%	6,685 $995,000
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $16,874 - $20,371	131 Added 1.96%	6,809 $958,000
Q1 2020 May 01, 2020	SELL	$111.14 - $153.99 $35,009 - $48,506	-315 Reduced 4.5%	6,678 $876,000
Q4 2019 Jan 21, 2020	SELL	$127.5 - $146.44 $3,060 - $3,514	-24 Reduced 0.34%	6,993 $1.02 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $66,521 - $74,481	-524 Reduced 6.95%	7,017 $908,000
Q2 2019 Jul 24, 2019	SELL	$131.15 - $144.24 $26,230 - $28,848	-200 Reduced 2.58%	7,541 $1.05 Million
Q1 2019 Apr 30, 2019	BUY	$125.72 - $139.79 $314,425 - $349,614	2,501 Added 47.73%	7,741 $1.08 Million
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $277,004 - $333,379	2,255 Added 75.54%	5,240 $676,000
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $2,985 - $3,294	25 Added 0.84%	2,985 $362,000
Q1 2018 May 04, 2018	BUY	$125.1 - $148.14 $4,628 - $5,481	37 Added 1.27%	2,960 $379,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,923	2,923 $387,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account